Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Finerenone for Retinal Vascular Dysfunction in CKD
NCT07235891Phase 4Not yet recruiting
- Sponsor
- Alexandria University
- Start
- Nov 2025
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of finerenone in retinal vascular disease, sponsored by Alexandria University. Planned start Nov 2025; status: not yet recruiting.
02
Drugs
finerenone
03
Conditions
retinal vascular disease
Beyond the preview
Go deeper on NCT07235891.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07235891.